metocurine

Known as: DMCDM, dimethylchondrocurarine, dimethylcurine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1977-2009
051019772009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
We investigated the effects of body size on the pharmacokinetics and pharmacodynamics of the renally cleared muscle relaxant… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Forty-six patients with severe nonpenetrating brain injury [Glasgow Coma Scale (GCS) 4-7] were randomized to standard management… (More)
Is this relevant?
1992
1992
Long-term phenytoin therapy induces resistance to the neuromuscular blocking effects of metocurine. The hypothesis that this is… (More)
Is this relevant?
1989
1989
Chronic muscle disuse decreases the sensitivity of skeletal muscle to nondepolarizing relaxants, such as metocurine (MTC). In… (More)
Is this relevant?
1987
1987
In order to determine whether a small, "defasciculating" dose of metocurine could prevent increases in intracranial pressure (ICP… (More)
Is this relevant?
1985
1985
The effects of age (older than 70 yr) on the pharmacokinetics and pharmacodynamics of d-tubocurarine (dTc) and metocurine (MTc… (More)
Is this relevant?
1985
1985
Recent reports have described resistance to pancuronium-induced neuromuscular blockade in patients chronically receiving… (More)
Is this relevant?
1980
1980
Simultaneous administration of combinations of pancuronium, metocurine, and d-tubocurarine (dTc) were given to A.S.A. class I-II… (More)
Is this relevant?
1979
1979
To compare the pharmacokinetics of d-tubocurarine and metocurine in man, concentrations of 3H-d-tubocurarine and 14C-metocurine… (More)
Is this relevant?
1979
1979
The potencies of metocurine and d-tubocurarine for neuromuscular and autonomic blockade and histamine release were determined in… (More)
Is this relevant?